20/10/2025 09:00
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd p OriginalResearch: SYNBIOTIC SE from NuWays AG br/br/ 20.10.2025 / 09:00 CET/CESTbr/ Dissemination of a Research, transmitted by EQS News a service of EQS Group.br/ The issuer is solely responsible for the content of this... Lire...
20/10/2025 09:00
Original-Research: Scandinavian Astor Group AB (von NuWays AG): BUY
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd p OriginalResearch: Scandinavian Astor Group AB from NuWays AG br/br/ 20.10.2025 / 09:00 CET/CESTbr/ Dissemination of a Research, transmitted by EQS News a service of EQS Group.br/ The issuer is solely responsible for the... Lire...
20/10/2025 08:58
Hot Rocks Investments plc: WeShop Holdings Limited
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd p Hot Rocks Investments plc HRIP br/ Hot Rocks Investments plc: WeShop Holdings Limited br/br/span20Oct2025 / 07:58 GMT/BST/spanbr/br//p hr/divdiv p... Lire...
20/10/2025 08:50
EQS-News: 11880 Solutions AG expands its review portal werkenntdenBESTEN: New design, review highlights and cooperation with GetYourGuide ensure better orientation
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: 11880 Solutions AG / Key words: Product Launch/Alliance br/ 11880 Solutions AG expands its review portal werkenntdenBESTEN: New design, review highlights and cooperation with... Lire...
20/10/2025 08:35
EQS-News: Nongshim Shin Ramyun Light Ups New York Times Square with 'KPop Demon Hunters'
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Nongshim / Key words: Agreement/Product Launch br/ Nongshim Shin Ramyun Light Ups New York Times Square with KPop Demon Hunters br/br/ 20.10.2025 / 08:35... Lire...
20/10/2025 08:30
TRANSGENE : Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
PRESS RELEASE Transgene and BioInvent’s Armed Oncolytic Virus BT001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors BT001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and... Lire...
20/10/2025 08:30
SOITEC: SOITEC AND CEA PARTNER TO DEVELOP AUTOMOTIVE CYBERSECURITY WITH ADVANCED FD-SOI TECHNOLOGY
SOITEC AND CEA PARTNER TO DEVELOP AUTOMOTIVE CYBERSECURITY WITH ADVANCED FDSOI TECHNOLOGY Bernin Grenoble, France, October 20, 2025 – As vehicles become increasingly software defined and connected, ensuring robust hardware cybersecurity is ever more critical. A modern car... Lire...
20/10/2025 08:30
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
Press Release ESMO: AlphaMedixTM phase 2 data support firstinclass potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors • New AlphaMedix data showed sustained and clinically meaningful responses across both RLT naïve and RLTexposed patients with... Lire...
20/10/2025 08:05
Tocvan Ventures Corp : Tocvan Advances Drilling, Trenching, and Pilot Mine Preparation, Mobilizing Equipment to North and South Blocks at Gran Pilar Gold-Silver Project
pstrong id=datelineCALGARY, AB / a href=https://www.accessnewswire.com/ACCESS Newswire/a / October 20, 2025 / /strongTocvan Ventures Corp. "Tocvan" or the "strongCompany/strong" CSE:TOCOTCQB:TCVNFWKN:TV3/A2PE64, is pleased to announce the mobilization of equipment to both the... Lire...